InvestorsHub Logo
Followers 13
Posts 1903
Boards Moderated 0
Alias Born 03/03/2011

Re: None

Friday, 10/11/2019 12:21:41 AM

Friday, October 11, 2019 12:21:41 AM

Post# of 7594
Geron Says First Patient Dosed In Phase 3 Clinical Trial
October 10, 2019
06:45 PM ETPublished October 10, 2019 06:45 PM Eastern Time
Reuters
Related Investments

Geron Corp
Last 3 Months
chart image for Geron Corp

Oct 10 (Reuters) - Geron Corp:

* GERON ANNOUNCES FIRST PATIENT DOSED IN IMERGE PHASE 3 CLINICAL TRIAL IN LOWER RISK MYELODYSPLASTIC SYNDROMES

* GERON CORP - EXPECTS TOP-LINE RESULTS FOR IMERGE PHASE 3 CLINICAL TRIAL TO BE AVAILABLE BY MID-YEAR 2022
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News